drugset / Trial / NCT02278198
Evaluation of Thyroid Stunning From a Diagnostic Dose of I-123
NaSingle-groupOpen-labelDiagnostic
Summary
The purpose of the study is to find out if the small dose of radioiodine, that is used for the dosimetry study on patients with differentiated thyroid cancer, may stun the cancer cells and make the thyroid cancer treatment less effective.
Timeline
- Start
- 2012-11-30
- Primary completion
- 2019-09-20
- Completion
- 2019-09-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | rhTSH | Protein / enzyme biologic | — | Intramuscular |